You are here: Home » Psychology Forums » Ask a Question Forum
(No subject)
Jakafi (ruxolitinib) is a prescription targeted therapy used to treat adults with rare blood disorders like myelofibrosis and polycythemia vera, as well as graft-versus-host disease (GVHD). It is taken orally, either as a twice-daily immediate-release tablet or as a once-daily extended-release (XR) tablet.
Visit: https://www.onlinegenericmedicine.com/jakavi-tablet
Replies to this message:
|
Author: |
Subject: |
Replies: |
Date: |
|
No posts in this forum yet. Be the first to post a message!
| |||
